You are here: Industry Insights > Flu A

News List

FDA Grants Emergency Use Authorization for COVID-19, Flu A, Flu B Combo Kit americanpharmaceuticalreview
February 19, 2021
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit from Thermo Fisher Scientific.
Cepheid Receives CE-IVD Registration for SARS-CoV-2, Flu A, Flu B, RSV Combination Test americanpharmaceuticalreview
December 10, 2020
Cepheid announced the CE-IVD marking of Xpert® Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample.
Mesa Biotech Receives $13 Million from HHS to Develop 30 Minute SARS-CoV-2 & Flu A/Flu B Test americanpharmaceuticalreview
November 17, 2020
Mesa Biotech has been awarded a contract up to $13 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human ...
Cepheid Receives EUA for SARS-CoV-2, Flu A, Flu B and RSV Combination Test americanpharmaceuticalreview
October 09, 2020
Cepheid has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19 ...